Wai Conrad 4

What Happened
Wai Conrad, CEO (Counterpart Health), was granted a time‑based restricted stock unit (RSU) award for 267,766 shares of Clover Health Class A common stock on April 1, 2026. The Form 4 reports the acquisition price as $0.00 (award/grant), so the reported acquisition value is $0. This is a compensation award rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-04-01; Form 4 filed: 2026-04-03 (appears timely).
• Transaction type/code: Award/Grant (A). Price reported: $0.00. Total shares granted: 267,766.
• Shares owned after transaction: not specified in the filing.
• Footnote F1: These are time‑based RSUs — 25% vest on Apr 1, 2027, then the remainder vests in 12 equal quarterly installments beginning three months after that date; fully vested on Apr 1, 2030, subject to continued service.
• Footnote F2: Some shares are held in a family trust for which the reporting person is a co‑trustee.

Context
RSU grants are typical executive compensation and do not represent an immediate market purchase or sale. These RSUs convert to actual shares only as they vest (subject to service conditions) and may have tax consequences upon vesting; they do not by themselves indicate buying or selling sentiment.